跳至主要内容
临床试验/NL-OMON23479
NL-OMON23479Other不适用

Crossover safety study of intranasal administration of palivizumab in healthy adults

ouis Bontl.bont@umcutrecht.nl0 个研究点目标入组 0 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
Other
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adult men and women between the ages of 18 and 50 in good health based on relevant medical history

排除标准

  • Adults with nasal cold or obstructions in the nasal cavity; history of respiratory symptoms or serious infectious disease within 4 weeks prior to drug administration; immunocomprimised; nasal surgery prior to or during trial

研究者

发起方
ouis Bontl.bont@umcutrecht.nl

相似试验